SCHEMBL4826503

SCHEMBL4826503

COc1ccc(S(=O)(=O)ON2C(=O)C3CC4C(=O)N(OS(=O)(=O)c5ccc(OC)cc5)C(=O)C4CC3C2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
MMP2 P08253 2/20 0.45
PKM P14618 2/20 0.45
NPC1 O15118 1/20 0.45
PKLR P30613 1/20 0.45
RAB9A P51151 1/20 0.45
HSD11B1 P28845 1/20 0.45
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 2/20 0.42
PARL Q9H300 2/20 0.41
MMP13 P45452 1/20 0.41
VDR P11473 1/20 0.41
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
EP300 Q09472 1/20 0.40
KAT2A Q92830 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4835021 0.86 GAA (0.49) GAAMMP2PKMNPC1PKLR
SCHEMBL4837258 0.84 VDR (0.58) GAAMMP2ALDH1A1CYP2D6HTT
SCHEMBL13473215 0.83 ALDH1A1 (0.51) GAAMMP2NPC1RAB9AHSD11B1
SCHEMBL4831931 0.83 KMT2A (0.55) MMP2PKMALDH1A1PARLVDR
SCHEMBL4830039 0.81 PARL (0.44) MMP2NPC1RAB9AALDH1A1HTT
SCHEMBL4832240 0.81 KDM4E (0.50) MMP2ALDH1A1HTTPARLVDR
SCHEMBL4837175 0.81 ALDH1A1 (0.50) MMP2HSD11B1ALDH1A1CYP3A4CYP2D6
SCHEMBL4831889 0.81 LIPE (0.44) MMP2PARLMMP9
SCHEMBL4834988 0.81 TSHR (0.49) PKMALDH1A1CYP3A4CYP2C19HTT
SCHEMBL4837033 0.81 PARL (0.64) MMP2NPC1RAB9AALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 GAA 2435/4885MMP2 4856/4885PKM 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.